FranΓ§aisπ See the interactive version (live chart) β
| Investment | Value today | Gain |
|---|---|---|
| 1 years ago (2025) | $1,811 | +81% |
| 3 years ago (2023) | $1,859 | +86% |
| 5 years ago (2021) | $4,100 | +310% |
| 10 years ago (2016) | $8,144 | +714% |
| since 2004 | $866 | -13% |
| Year | Year's return | $1,000 invested at year start β worth today |
|---|---|---|
| 2026 (YTD) | +34% | $1,341 (+34%) |
| 2025 | +35% | $1,811 (+81%) |
| 2024 | -44% | $1,020 (+2%) |
| 2023 | +82% | $1,859 (+86%) |
| 2022 | +1% | $1,869 (+87%) |
| 2021 | +119% | $4,100 (+310%) |
| 2020 | +96% | $8,029 (+703%) |
| 2019 | +68% | $13,479 (+1248%) |
| 2018 | -22% | $10,453 (+945%) |
| 2017 | -33% | $7,012 (+601%) |
| 2016 | +16% | $8,144 (+714%) |
π See the analyst analysis of Cytokinetics β
$1000 invested in Cytokinetics 5 years ago would be worth $4,100 today, and $8,144 over 10 years (price return, excluding dividends).
Calendar-year returns β 2024: -44%. 2025: +35%. 2026: +34%. Full breakdown in the table above.
Over 10 years, Cytokinetics's average annual return (CAGR) is about 23% per year, and 33%/yr over 5 years.
Best year: 2021 (+119%). Worst year: 2024 (-44%).
It's proportional β just multiply. Over 5 years, $1,000 invested in Cytokinetics is worth $4,100, so $100 would be worth a tenth, $5,000 five times more, and $10,000 ten times more. Use the calculator at the top of the page for your exact amount and chosen year.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Past performance, no predictive value and not investment advice. Prices in $, excluding dividends. Data: Yahoo Finance.